Hong Wu

1.4k citations
59 papers · 930 indexed · h-index 16
Topics
Cancer Immunotherapy and Biomarkers (6 papers)Immune cells in cancer (6 papers)MicroRNA in disease regulation (4 papers)

In The Last Decade

Hong Wu

53 papers receiving 920 citations

Peers

Hong Wu
Comparison fields: 5 of 144
  • Molecular Biology 356
  • Cancer Research 175
  • Oncology 162
  • Biomedical Engineering 131
  • Immunology 106
Replace Jiguang Bao with:
Jiguang Bao China
Zhaoyang Zhang China
Xiao Peng Zhang China
Yi-Cheng Chen Taiwan
Robyn P. Araujo Australia
John Virostko United States
Cesar A. Vargas-García United States
Guannan Zhao United States
Mohammad Kohandel Canada
Jiang Wang China
Hong Wu relative to Jiguang Bao China Jiguang Bao's profile →
Citations per field
00.5×1.5×2.3×
Jiguang Bao · 1×
Citations per year

Countries citing papers authored by Hong Wu

Since Specialization
Citations

This map shows the geographic impact of Hong Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hong Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hong Wu more than expected).

Fields of papers citing papers by Hong Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hong Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hong Wu. The network helps show where Hong Wu may publish in the future.

Co-authorship network of co-authors of Hong Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Hong Wu. A scholar is included among the top collaborators of Hong Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hong Wu. Hong Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 3
2 3
3 0
4 8
5 1
6 0
7 5
8 0
9 9
10 0
11 11
12 1
13 35
14 34
15 3
16
MiR-155 affects proliferation and apoptosis of bladder cancer cells by regulating GSK-3β/β-catenin pathway
1
17 26
18 47
19
Variation trend of the tetrapeptide on the tip of V3 loop of 62 HIV-1 strains isolated in idu of Yunnan from 1990 to 1997
2
20 37

About Hong Wu

Hong Wu is a scholar working on Oncology, Cancer Research and Immunology, having authored 59 papers that have together received 930 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (6 papers), Immune cells in cancer (6 papers) and MicroRNA in disease regulation (4 papers). The work is most often cited by research in Cancer Research (175 citations), Oncology (162 citations) and Molecular Biology (356 citations). Hong Wu has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Chuan Xu, Yuexin Han, Wei‐Jiang Gong, Yajun Wang, Yiqiang Liu, Xiu‐Wu Bian, Hongbo Zou, Ying Shi, Guoxiang Jin and Kun Zhang. Their work appears in journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Applied Physics Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026